Skip to main content

Haemophilia B Without Inhibitor clinical trials at UCSF
2 in progress, 0 open to eligible people

  • ATHN 7: Hemophilia Natural History Study

    Sorry, not currently recruiting here

    This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-approved treatment to be used which may include non-factor products, bypassing agents, or clotting factor replacement products. The goal of this research is to study the use of hemophilia treatment products and their outcomes.

    San Francisco, California and other locations

  • ATHN 8: PUPs Matter Study

    Sorry, not currently recruiting here

    This is a multi-center cohort study of approximately 250 previously untreated patients (PUPs) with congenital moderate to severe hemophilia A or B in a network of up to 50 US Hemophilia Treatment Centers (HTCs). Participants will be followed as they receive their first 50 exposure days (ED) to clotting factor replacement product, both prospectively and retrospectively. The data collected on evolving treatment practices will define the incidence and risk factors for inhibitor development during the high risk period of first 50 ED and improve the outcomes of this vulnerable population.

    San Francisco, California and other locations

Last updated: